New research from Monash Institute of Pharmaceutical Sciences (MIPS), in collaboration with the Max Planck Institute, Mayo Clinic, University of Auckland, University of Essex and University of Tokyo, has uncovered new structures of protein
Monash University researchers have produced the first known mRNA COVID-19 vaccine candidates in Australia using an advanced technological approach capable of generating vaccines ready for human testing in record time.
Simple works best: Monash University study finds a way to reduce medicine risk for older Australians
Almost one million Australians aged 70+ are regularly taking five or more prescription medicines. The Royal Commission on Aged Care Quality and Safety has highlighted complex medication regimens as a risk to the health and safety of older people.
12 January 2015
A novel drug delivery technology, developed by researchers at the Monash Institute of Pharmaceutical Sciences (MIPS), has been acquired by Capsugel, a global leader in innovative dose-form development.
23 Jan 2017
Researchers have discovered that the hormone, insulin, which regulates energy metabolism in humans, is used by a marine snail to subdue and capture its prey.
A group of sixteen researchers from the Monash Institute of Pharmaceutical Sciences will be hanging up the lab coats and putting on their running shoes for the 2015 Mother's Day Classic.
Professor Jonathan Baell from MIPS has collaborated with researchers from the Peter MacCallum Cancer Centre to discover a new way to target acute myeloid leukaemia (AML) at its source - a discovery that could yield a more effective